KIT and gastrointestinal stromal tumor: GIST-T1/670 has acquired a T670I gatekeeper mutation and as expected is sensitive to sunitinib which targets exon 13 (V654A) and exon 14 (T670I) mutations and GIST-T1/10R is resistant to all three KIT inhibitors (S1A Fig).